Hertfordshire Local Resilience Forum Stakeholder Update 29 October 2021 A message from Genna Telfer, Assistant Chief Constable a
![Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded,](https://www.thelancet.com/cms/attachment/994abe4d-01fd-4a3c-9a37-fca8ec3521f2/gr1.gif)
Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded,
We are busy updating our site to make it an even better experience for you. Normal service will resume on Sunday evening. In the
We are busy updating our site to make it an even better experience for you. Normal service will resume on Sunday evening. In the
1 January 2021 Dear Parent/Carers and students of Ridgeway Academy Happy new year! I hope you all enjoyed the festive period des
10 December 2021 Dear parents and carers Covid-19 measures We continue to be vigilant as a School community to look out for all
![Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial - Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial -](https://www.thelancet.com/cms/attachment/966d70c5-8395-4ea2-9a35-94dc18f2f550/gr1.gif)
Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial -
Special Issue on New coronavirus (2019‐nCoV or SARS‐CoV‐2) and the outbreak of the respiratory illness (COVID‐19): Part‐VI: Journal of Medical Virology: Vol 92, No 10
![Viruses | Free Full-Text | Incursion of European Bat Lyssavirus 1 (EBLV-1) in Serotine Bats in the United Kingdom Viruses | Free Full-Text | Incursion of European Bat Lyssavirus 1 (EBLV-1) in Serotine Bats in the United Kingdom](https://www.mdpi.com/viruses/viruses-13-01979/article_deploy/html/images/viruses-13-01979-g001.png)